- Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
-
Choi SY, Kang B, Lee JH, Choe YH
- KMID: 2412155
- Gut Liver.
- 2017 Jan;11(1):55-61.
- doi: 10.5009/gnl16041
BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these... -
- CITED
-
- Close
- SHARE
-
- Close
